Stents vs Bypass: How Cardiologists Decide Which You Need

Cardiac Surgery · 6 · March 4, 2026

You've just been told you have significant coronary artery disease. The cardiologist mentions two options: stents or bypass surgery. Both sound intimidating. And the decision between them isn't always straightforward. But there are clear evidence-based guidelines that help doctors choose. Let's break them down.

What Stenting Actually Involves

Percutaneous coronary intervention — PCI — is the technical term. A catheter is threaded through the wrist or groin artery to the blocked coronary artery. A balloon expands to open the narrowing, and a metal mesh tube (stent) is deployed to keep it open. Modern drug-eluting stents are coated with medication that prevents the artery from re-narrowing. The procedure takes 30-90 minutes. Most patients go home the same day or the next morning.

Recovery is fast. You're walking within hours. Back to work in a week. The main commitment is dual antiplatelet therapy — aspirin plus a P2Y12 inhibitor like clopidogrel or ticagrelor — for 6-12 months to prevent stent thrombosis.

What Bypass Surgery Involves

Coronary artery bypass grafting — CABG (pronounced "cabbage") — is open-heart surgery. The surgeon harvests vessels from the chest wall (internal mammary artery), leg (saphenous vein), or arm (radial artery) and sews them to bypass the blocked sections. It requires general anesthesia, a sternotomy (splitting the breastbone), and typically 4-7 days in the hospital. Full recovery takes 6-12 weeks.

That sounds brutal compared to stenting. So why would anyone choose bypass? Because in certain situations, it's dramatically better.

The SYNTAX Score: Anatomy Drives the Decision

The SYNTAX trial (2009, with 10-year follow-up in 2019) created a scoring system based on coronary anatomy complexity. A SYNTAX score below 22 means relatively simple disease — stenting and bypass produce equivalent outcomes. A score between 23-32 is intermediate. Above 32 means complex disease where bypass is clearly superior.

The 10-year data was unambiguous: for patients with three-vessel disease or left main disease with high SYNTAX scores, CABG reduced all-cause mortality by 24% compared to stenting. The survival curves separated by year 5 and kept diverging. That's a big deal.

Diabetes Changes Everything

If you have diabetes and multi-vessel coronary disease, bypass is almost always the right choice. The FREEDOM trial, published in NEJM in 2012 with extended follow-up through 2022, showed that bypass reduced all-cause mortality by 33% and heart attacks by 44% compared to stenting in diabetic patients. The benefit was consistent across subgroups.

Why? Diabetic patients have diffuse atherosclerosis — disease throughout the length of the arteries, not just focal blockages. Stents treat spots. Bypass jumps over entire diseased segments. And the internal mammary artery graft, when connected to the left anterior descending artery, has a patency rate above 90% at 20 years. No stent comes close to that durability.

When Stenting Wins

For single-vessel disease, stenting is the clear winner. Less invasive, faster recovery, equivalent outcomes. For acute heart attacks (STEMI), emergency PCI is the standard of care — you need the artery open within 90 minutes, and there's no time for bypass surgery. And for patients who are too frail or sick for open-heart surgery, stenting provides a viable option where none existed before.

The Heart Team Approach

Current guidelines require a "heart team" discussion for complex cases — an interventional cardiologist, a cardiac surgeon, and the patient. The 2024 ESC/EACTS guidelines emphasize shared decision-making. Your preferences matter. If two options produce similar survival statistics, the one that fits your life — recovery time, risk tolerance, activity goals — should win.

Key Takeaways

- Single-vessel disease: stenting is preferred — same outcomes with faster recovery

- Three-vessel or left main disease with high SYNTAX score: bypass reduces mortality by 24% over 10 years

- Diabetic patients with multi-vessel disease should strongly consider bypass (FREEDOM trial: 33% mortality reduction)

- Emergency heart attacks require immediate stenting — bypass is for planned revascularization

- A heart team discussion (surgeon + cardiologist + patient) is the standard for complex decisions

Considering cardiac surgery and want to compare options globally? Use our global cost comparison tool to see pricing for stenting and bypass across 15 countries.